Inhaler devices for patients with COPD. [Review]
Citation: Copd: Journal of Chronic Obstructive Pulmonary Disease. 10(4):523-35, 2013 Aug.PMID: 23537191Institution: MedStar Washington Hospital CenterDepartment: Medicine/Pulmonary-Critical CareForm of publication: Journal ArticleMedline article type(s): Journal Article | ReviewSubject headings: *Nebulizers and Vaporizers | *Patient Preference | *Pulmonary Disease, Chronic Obstructive/dt [Drug Therapy] | Adrenergic beta-Agonists/ad [Administration & Dosage] | Bronchodilator Agents/ad [Administration & Dosage] | Cholinergic Antagonists/ad [Administration & Dosage] | Dry Powder Inhalers | Humans | Metered Dose Inhalers | Time FactorsYear: 2013ISSN:- 1541-2563
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 23537191 | Available | 23537191 |
Chronic obstructive pulmonary disease (COPD) continues to be associated with increased morbidity and mortality risk in spite of updated guidelines and a better understanding of this condition. Progressive airflow limitation and resultant hyperinflation-the respiratory hallmarks of this complex and often under-diagnosed disease-can be treated with pharmacotherapies emitted via nebulizers, pressurized metered-dose inhalers, dry powder inhalers, or a Soft Mist inhaler. Pharmaceutical company proprietary issues, technological innovations, and societal pressure have expanded the list of available inhalers, with a limited range of medications available for any one device. Each device has different operating and maintenance instructions, and successful use of a given drug/device combination requires that patients understand, maintain, and use each of their devices properly in order to ensure consistent and optimal pulmonary drug delivery. Clinicians are faced with a range of physical and psychosocial issues unique to each patient with COPD that must be overcome in order to match a suitable inhaler to the individual. Improved drug delivery afforded by next-generation inhalers, coupled with an awareness of device-specific and patient-specific variables affecting inhaler use, may improve clinical outcomes in the treatment of COPD.
English